CFCThe Compounder Score
WAT logo

WAT — Waters Corporation

Diagnostics & ResearchHealthcare

$460.25

$-1.95 (-0.42%)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.

Market Cap

$90.45B

Forward P/E

27.8x

52-Week Range

N/A

WAT Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$3.2B

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$540M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

21.5%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

2.0x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

3.6%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+0.3%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).